Replies to post #127112 on Biotech Values

[DewDiligence]

The $450M Copaxone figure in #msg-67293937 takes into account the (less than certain) probability of success and the sharing of profits with NVS. The figure is probably near the low end of what’s reasonable, but I was trying to be conservative.